600713.SH
南京医药
SSE · Healthcare · Medical - Distribution · CN
CNY 5.16
−0.77%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 54.6B | 55.0B | 53.7B | 53.6B | 50.2B |
| Cost of Revenue | 51.2B | 51.6B | 50.3B | 50.3B | 47.0B |
| Gross Profit | 3.4B | 3.4B | 3.4B | 3.3B | 3.3B |
| Operating Expenses | |||||
| R&D Expense | 45.3M | 46.8M | 30.6M | 36.2M | 27.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 520.4M | 513.5M | 517.7M | 517.4M | 487.1M |
| Selling & Marketing Expense | 1.2B | 1.2B | 1.1B | 1.2B | 1.2B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 2.3B | 2.3B | 2.3B | 2.4B | 2.2B |
| Cost and Expenses | 53.5B | 53.9B | 52.7B | 52.6B | 49.2B |
| Operating Income (EBIT) | 1.2B | 1.2B | 1.0B | 1.0B | 934.3M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 1.2B | 1.2B | 1.0B | 978.1M | 906.0M |
| Income Tax Expense | 334.4M | 325.0M | 260.3M | 265.3M | 190.1M |
| Bottom Line | |||||
| Net Income | 622.0M | 624.8M | 570.6M | 577.8M | 595.7M |
| Earnings from Cont. Ops | 828.8M | 832.7M | 743.1M | 712.8M | 715.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 622.0M | 624.8M | 570.6M | 577.8M | 595.7M |
| Per Share | |||||
| Basic EPS | CN¥0.48 | CN¥0.48 | CN¥0.44 | CN¥0.45 | CN¥0.48 |
| Diluted EPS | CN¥0.48 | CN¥0.43 | CN¥0.44 | CN¥0.45 | CN¥0.48 |
| Revenue Per Share | CN¥42.51 | CN¥42.22 | CN¥41.22 | CN¥41.27 | CN¥40.05 |
| Shares | |||||
| Basic Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B |
| Diluted Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B |
| Profitability Metrics | |||||
| EBITDA | — | 1.4B | 1.2B | 1.2B | 1.1B |
| D&A | — | 193.6M | 170.6M | 172.1M | 169.9M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026